BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30288404)

  • 1. Introducing
    Schwartz AJ
    MDM Policy Pract; 2016; 1(1):2381468316661547. PubMed ID: 30288404
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing MDM Policy & Practice.
    Schwartz AJ
    Med Decis Making; 2016 Jan; 36(1):3-4. PubMed ID: 26670945
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting.
    Rogers MJ; Matheson L; Garrard B; Maher B; Cowdery S; Luo W; Reed M; Riches S; Pitson G; Ashley DM
    Public Health; 2017 Aug; 149():74-80. PubMed ID: 28575751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in France.
    Caudron A; Chaby G; Dadban A; Andrejak C; Dhaille F; Bagot M; Lok C
    Eur J Dermatol; 2010; 20(6):778-84. PubMed ID: 20959274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a peer-review framework for cancer multidisciplinary meetings.
    Johnson CE; Slavova-Azmanova N; Saunders C
    Intern Med J; 2017 May; 47(5):529-535. PubMed ID: 28105750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences on multidisciplinary team decision-making.
    Lanceley A; Savage J; Menon U; Jacobs I
    Int J Gynecol Cancer; 2008; 18(2):215-22. PubMed ID: 17511801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular abnormalities of mdm-2 in human sarcomas.
    Buesoramos C; Yang Y; Manshouri T; Feltz L; Ayala A; Glassman A; Albitar M
    Int J Oncol; 1995 Nov; 7(5):1043-8. PubMed ID: 21552929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 60 Gb/s MDM-WDM Si photonic link with < 0.7 dB power penalty per channel.
    Driscoll JB; Chen CP; Grote RR; Souhan B; Dadap JI; Stein A; Lu M; Bergman K; Osgood RM
    Opt Express; 2014 Jul; 22(15):18543-55. PubMed ID: 25089474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop.
    Almog N; Milyavsky M; Stambolsky P; Falcovitz A; Goldfinger N; Rotter V
    Carcinogenesis; 2001 May; 22(5):779-85. PubMed ID: 11323398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis.
    Bueso-Ramos CE; Manshouri T; Haidar MA; Huh YO; Keating MJ; Albitar M
    Leuk Lymphoma; 1995 Mar; 17(1-2):13-8. PubMed ID: 7773150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas.
    Seki A; Kodama J; Miyagi Y; Kamimura S; Yoshinouchi M; Kudo T
    Int J Cancer; 1997 Sep; 73(1):33-7. PubMed ID: 9334806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mdm-2 and p53 protein in transitional cell carcinoma.
    Barbareschi M; Girlando S; Fellin G; Graffer U; Luciani L; Dalla Palma P
    Urol Res; 1995; 22(6):349-52. PubMed ID: 7537927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical value of mdm-2 (proto-oncogene) expression in testicular cancer, Correlation with tumor progression].
    Bak M; Géczi L; Institioris E; Eid H; Bodrogi I
    Orv Hetil; 1999 Aug; 140(33):1837-40. PubMed ID: 10489783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53.
    Berberich S; Cole M
    Oncogene; 1994 May; 9(5):1469-72. PubMed ID: 8152809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance.
    Haidar MA; El-Hajj H; Bueso-Ramos CE; Manshouri T; Glassman A; Keating MJ; Maher A
    Am J Hematol; 1997 Mar; 54(3):189-95. PubMed ID: 9067496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas.
    Finnegan MC; Goepel JR; Royds J; Hancock BW; Goyns MH
    Cancer Lett; 1994 Nov; 86(2):215-21. PubMed ID: 7982210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM-1 and MDM-2: two mutator-derived MITE families in rice.
    Yang G; Hall TC
    J Mol Evol; 2003 Mar; 56(3):255-64. PubMed ID: 12612829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrapressure liquid chromatography-tandem mass spectrometry assay using atmospheric pressure photoionization (UPLC-APPI-MS/MS) for quantification of 4-methoxydiphenylmethane in pharmacokinetic evaluation.
    Farhan N; Fitzpatrick S; Shim YM; Paige M; Chow DS
    J Pharm Biomed Anal; 2016 Sep; 128():46-52. PubMed ID: 27232150
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Med Decis Making; 2024 May; ():272989X241258539. PubMed ID: 38804642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multidisciplinary meetings in oncology do not impact the physician-patient relationship].
    Orgerie MB; Duchange N; Pélicier N; Rosset P; Lemarié E; Dorval E; Chapet S; Hervé C; Moutel G
    Presse Med; 2012 Mar; 41(3 Pt 1):e87-94. PubMed ID: 22079306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.